| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.75B | +48.9% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥-0.11B | — |
| Net income | ¥-0.10B | — |
| Gross margin | 11.6% | Net margin -13.9% |
| Revenue Q/Q | -8.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.67B | 88.4% |
| R&D | ¥0.02B | 2.2% |
| SG&A | ¥0.11B | 14.7% |
| Tax & other | ¥-0.00B | -0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
北路智控 ・ 唯科科技 ・ 工大科雅 ・ 喜悦智行 ・ 迈赫股份 ・ 大族数控 ・ 诚达药业 ・ 朗威股份 ・ 国泰环保 ・ 联特科技 ・ 三元生物 ・ 华兰疫苗
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies